Neurology Clinical Trials

Statistical methods in neurology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All neurology trials

816 results

• A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression: Complete Statistical AnalysisIndependent statistical analysis of A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 81NCT03044249
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 821NCT01247324
• A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 191NCT00930059
• A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis: Complete Statistical AnalysisIndependent statistical analysis of A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 108NCT00812006
• A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia: Complete Statistical AnalysisIndependent statistical analysis of A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 246NCT00710554
• A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.: Complete Statistical AnalysisIndependent statistical analysis of A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 125NCT00711880
• A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 352NCT05163314
• A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 144NCT04940624
• A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 73NCT01087203
• A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS: Complete Statistical AnalysisIndependent statistical analysis of A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 4Results postedn = 64NCT02208050
• A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD): Complete Statistical AnalysisIndependent statistical analysis of A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD): primary endpoint results, effect estimate…Phase 2/3Results postedn = 32NCT01896102
• A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 223NCT00150709
• A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005): Complete Statistical AnalysisIndependent statistical analysis of A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 170NCT00529659
• A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson’s Disease Psychosis: Complete Statistical AnalysisIndependent statistical analysis of A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 298NCT00477672
• A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 55NCT02495844
• A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006): Complete Statistical AnalysisIndependent statistical analysis of A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 2,808NCT01340937
• A Study of V950 in People With Alzheimer Disease (V950-001 AM7): Complete Statistical AnalysisIndependent statistical analysis of A Study of V950 in People With Alzheimer Disease (V950-001 AM7): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1Results postedn = 86NCT00464334
• A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults: Complete Statistical AnalysisIndependent statistical analysis of A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 1/2Results postedn = 45NCT00745251
• A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase NAResults postedn = 28NCT02526277
• A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study): Complete Statistical AnalysisIndependent statistical analysis of A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study): primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 144NCT01136954
• A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting: Complete Statistical AnalysisIndependent statistical analysis of A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting: primary endpoint results, effect estimate with…Phase 2Results postedn = 46NCT03021018
• A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD): Complete Statistical AnalysisIndependent statistical analysis of A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD): primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 119NCT04138277
• A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.: Complete Statistical AnalysisIndependent statistical analysis of A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 609NCT02174861
• A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET): Complete Statistical AnalysisIndependent statistical analysis of A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET): primary endpoint results, effect estimate with…Phase 2Results postedn = 420NCT05122650
• A Study to Characterize Diclofenac’s Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty: primary endpoint…Phase 1Results postedn = 47NCT03497039
• A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted: Complete Statistical AnalysisIndependent statistical analysis of A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted: primary endpoint results, effect estimate with…Phase 1Results postedn = 45NCT01775189
• A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain: Complete Statistical AnalysisIndependent statistical analysis of A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 19NCT00713817
• A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 243NCT03206749
• A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05677256).Phase 4Results postedn = 501NCT05677256
• A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 11NCT03343067
• A Study to Evaluate SAGE-217 in Participants With Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03000569).Phase 2Results postedn = 29NCT03000569
• A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington’s Disease (HD): Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 189NCT05107128
• A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 102NCT02545868
• A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson’s Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of…Phase 3Results postedn = 307NCT03881371
• A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy: primary endpoint results, effect estimate with confidence interval,…Phase 3Results postedn = 854NCT00478023
• A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087): Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 109NCT00894556
• A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 337NCT01599234
• A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA).: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA).: primary endpoint results, effect estimate with confidence interval,…Phase 1Results postedn = 24NCT03923738
• A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis: primary endpoint results, effect estimate with confidence interval,…Phase 3Results postedn = 31NCT06471361
• A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD): Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD): primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 119NCT04660539
• A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson’s Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations: Complete Statistical AnalysisIndependent statistical analysis of A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing…Phase 2Results postedn = 75NCT00165789
• A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy: Complete Statistical AnalysisIndependent statistical analysis of A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy: primary endpoint results, effect estimate with…Phase 2Results postedn = 134NCT01201317
• A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 44NCT02683785
• A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis: Complete Statistical AnalysisIndependent statistical analysis of A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 71NCT04124965
• A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich’s Ataxia: Complete Statistical AnalysisIndependent statistical analysis of A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia: primary endpoint results, effect estimate with…Phase 2Results postedn = 172NCT02255435
• A Study to Learn How Well a Single Dose of the Study Treatment Naproxen Sodium and Caffeine Combined in One Tablet (Fixed-dose Combination) Works to Relieve Pain After Dental Surgeries Compared to the Single Ingredients and to Placebo: Complete Statistical AnalysisIndependent statistical analysis of A Study to Learn How Well a Single Dose of the Study Treatment Naproxen Sodium and Caffeine Combined in One Tablet (Fixed-dose Combination) Works to Relieve Pain After…Phase 3Results postedn = 541NCT05485805
• A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation – XR: Complete Statistical AnalysisIndependent statistical analysis of A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 158NCT00368069
• A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis: Complete Statistical AnalysisIndependent statistical analysis of A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 200NCT03971422
• A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age: primary endpoint results, effect estimate with confidence interval,…Phase 3Results postedn = 292NCT04464707
• A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH): Complete Statistical AnalysisIndependent statistical analysis of A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 87NCT03347188

← All therapeutic areas